Who owns PALVELLA THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PVLA from SEC Form 13F filings across 199 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 199 institutions disclosed 14.6M shares of PALVELLA THERAPEUTICS, INC. worth $2.01B — about 100.3% of shares outstanding; the largest disclosed holder is JENNISON ASSOCIATES LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
199
13F holders
$2.01B
value, 2026 filers
100.3%
of shares outstanding (14.6M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PVLA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | JENNISON ASSOCIATES LLC | 1.1M | $152.0M | 0.1% | 7.6% | +14.7% |
| 2 | MONTANOVA CAPITAL, LLC | 1.0M | $144.1M | 3.4% | 7.2% | -8.0% |
| 3 | BlackRock, Inc. | 989,691 | $136.5M | 0.0% | 6.8% | +7.8% |
| 4 | Frazier Life Sciences Management, L.P. | 882,400 | $121.7M | 3.0% | 6.1% | 0.0% |
| 5 | First Light Asset Management, LLC | 734,086 | $101.3M | 6.0% | 5.1% | -4.9% |
| 6 | STATE STREET CORP | 624,879 | $86.2M | 0.0% | 4.3% | -4.3% |
| 7 | BVF INC/IL | 607,149 | $83.7M | 2.8% | 4.2% | -9.8% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 591,995 | $81.7M | 0.0% | 4.1% | -7.3% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 540,712 | $74.6M | 0.0% | 3.7% | +5.2% |
| 10 | WESTFIELD CAPITAL MANAGEMENT CO LPNEW | 396,045 | $54.6M | 0.2% | 2.7% | new |
| 11 | FEDERATED HERMES, INC. | 332,422 | $45.9M | 0.1% | 2.3% | -23.2% |
| 12 | MARSHALL WACE, LLP | 329,799 | $45.5M | 0.0% | 2.3% | +11463.8% |
| 13 | Invesco Ltd. | 312,729 | $43.1M | 0.0% | 2.2% | +829.3% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 311,596 | $43.0M | 0.0% | 2.1% | +12.8% |
| 15 | FRONTIER CAPITAL MANAGEMENT CO LLC | 276,272 | $38.1M | 0.4% | 1.9% | -42.3% |
| 16 | PRIMECAP MANAGEMENT CO/CA/ | 268,609 | $37.0M | 0.0% | 1.8% | +4.9% |
| 17 | ALLIANCEBERNSTEIN L.P. | 254,969 | $35.2M | 0.0% | 1.8% | +0.7% |
| 18 | Woodline Partners LP | 250,517 | $34.6M | 0.1% | 1.7% | -21.1% |
| 19 | EVENTIDE ASSET MANAGEMENT, LLC | 231,484 | $31.9M | 0.4% | 1.6% | 0.0% |
| 20 | ORBIMED ADVISORS LLC | 229,860 | $31.7M | 0.6% | 1.6% | -21.4% |
| 21 | EMERALD ADVISERS, LLC | 229,404 | $31.6M | 0.9% | 1.6% | 0.0% |
| 22 | Siren, L.L.C. | 207,485 | $28.6M | 0.7% | 1.4% | -19.4% |
| 23 | MPM BIOIMPACT LLC | 197,633 | $27.3M | 2.0% | 1.4% | -3.1% |
| 24 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCNEW | 195,070 | $26.9M | 0.1% | 1.3% | new |
| 25 | Bellevue Group AG | 155,000 | $21.4M | 0.4% | 1.1% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.